Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IV Study to Assess the Safety and Effectiveness of Dienogest (Visanne) Amongst Indian Women With Endometriosis, in Real-world Clinical Practice: the VISAGE Study

Next Previous
Trial Profile

Phase IV Study to Assess the Safety and Effectiveness of Dienogest (Visanne) Amongst Indian Women With Endometriosis, in Real-world Clinical Practice: the VISAGE Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dienogest (Primary)
  • Indications Endometriosis
  • Focus Adverse reactions
  • Acronyms VISAGE
  • Sponsors Bayer

Most Recent Events

  • 22 Jan 2025 Status changed from active, no longer recruiting to completed.
  • 20 Dec 2024 Planned End Date changed from 30 Nov 2024 to 31 Dec 2024.
  • 18 Oct 2024 Planned End Date changed from 20 Sep 2024 to 30 Nov 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top